Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Technology-Enabled Activation of Skin Cancer Screening for Hematopoietic Cell Transplantation Survivors and Their Primary Care Providers (TEACH)

NCT04358276 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT04358276
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04358276 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Technology-Enabled Activation of Skin Cancer Screening for Hematopoietic Cell Transplantation Survivors and Their Primary Care Providers (TEACH)
Lead sponsor
City of Hope Medical Center
Phase
Not applicable
Overall status
Active, not recruiting
Start date
October 30, 2020
Completion date
July 30, 2026
Enrollment
840 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

skin carcinoma